Oxford Gene Technology in Collaboration with Optra Systems to Develop Analysis Software
News Feb 27, 2009
Oxford Gene Technology (OGT) has announced a collaboration with Optra Systems, a Life Science and Healthcare IT consultancy company with expertise in biomedical imaging, to develop visualization and analysis software.
The collaboration was established to develop software to visualize and analyze data generated from high resolution scanners. The project is now in the testing phase following initial software development.
“We are developing an exciting portfolio of technologies to enable researchers to investigate gene expression in single cells,” said Dr John Anson, OGT’s R&D Director. “Image analysis is an integral part of these developments, and we chose Optra Systems for its expertise and excellent service. We are evaluating outsourcing opportunities for a further pilot project to develop a more powerful version of the software, and look forward to continuing our relationship with Optra Systems.”
Abhi Gholap, President and CEO of Optra Systems, said: “This is an exciting time for Optra Systems. Our biomedical imaging and application development expertise is well suited to building a powerful software analysis solution for the innovative platform in development at OGT, and we look forward to taking the project into the next phase.”
In treating inflammatory bowel disease (IBD), physicians can have a hard time telling which newly diagnosed patients have a high risk of severe inflammation or what therapies will be most effective. Now researchers report finding an epigenetic signature in patient cells that appears to predict inflammation risk in a serious type of IBD called Crohn’s disease.